Integrated safety and risk assessment for medical devices and combination products / Shayne C. Gad.
Gad, Shayne C., 1948- author.
2019
R856.6 .G33 2019eb
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Integrated safety and risk assessment for medical devices and combination products / Shayne C. Gad.
Author Gad, Shayne C., 1948- author.
ISBN 9783030352417 (electronic book)
3030352412 (electronic book)
3030352404
9783030352400
DOI https://doi.org/10.1007/978-3-030-35
Published Cham, Switzerland : Springer, [2019]
Language English
Description 1 online resource
Item Number 10.1007/978-3-030-35
Call Number R856.6 .G33 2019eb
Dewey Decimal Classification 681.7610289
Summary While the safety assessment ("biocompatibility") of medical devices has been focused on issues of local tissue tolerance (irritation, sensitization, cytotoxicity) and selected quantal effects (genotoxicity and acute lethality) since first being regulated in the late 1950s, this has changed as devices assumed a much more important role in healthcare and became more complex in both composition and in their design and operation. Add to this that devices now frequently serve as delivery systems for drugs, and that drugs may be combined with devices to improve device performance, and the problems of ensuring patient safety with devices has become significantly more complex. A part of this, requirements for ensuring safety (once based on use of previously acceptable materials - largely polymers and metals) have come to requiring determining which chemical entities are potentially released from a device into patients (and how much is released). Then an appropriate and relevant (yet also conservative) risk assessment must be performed for each identified chemical structure. The challenges inherent in meeting the current requirements are multifold, and this text seeks to identify, understand, and solve all of them. Identify and verify the most appropriate available data. As in most cases such data is for a different route of exposure, transform it for use in assessing exposure by the route of interest. As the duration (and rate) of exposure to moieties released from a device are most frequently different (longer) than what available data speaks to, transformation across tissue is required. As innate and adaptive immune responses are a central part of device/patient interaction, assessing potential risks on this basis are required. Incorporating assessments for special populations such as neonates. Use of (Q)SAR (Quantitative Structure Activity Relationships) modeling in assessments. Performance and presentation of integrative assessments cov ering all potential biologic risks. Appendices will contain summarized available biocompatibility data for commonly used device materials (polymers and metals) and safety assessments on the frequently seen moieties in extractions from devices.
Bibliography, etc. Note Includes bibliographical references and index.
Access Note Access limited to authorized users.
Source of Description Description based on online resource; title from digital title page (viewed on March 13, 2020).
Available in Other Form Print version: 9783030352400
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
1. Introduction
History and Where We are Headed
2. Regulatory Guidance
3. Sample Preparation and Biocompatibility Testing
4. Testing for Leachables and Extractables
5. Where the Data is
And What is It?
6. Bridging Issues of Route
7. Risk Assessments for Medical Devices
8. (Q)SAR
9. Histopathology in Medical Device Studies
10. Assessment of Nanomaterial Devices
11. Integrated Safety Assessments for Devices
12. Toxicity of Common Extractables and Leachables.

Browse Subjects

Show more subjects...

Statistics

from
to
Export